As the use of glucagon-like peptide 1 receptor agonists continues to exponentially expand obesity treatment, concerns have arisen regarding their impact on nutrition in people who take them
A new evidence-based guideline recommends prescribing metformin when initiating antipsychotic treatment to help mitigate weight gain in certain instances.